|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07C 217/74 | (2006.01) |
| C07C 215/64 | (2006.01) | ||
| C07D 265/16 | (2006.01) | ||
| C07B 59/00 | (2006.01) | ||
| C07C 211/64 | (2006.01) |
| (11) | Number of the document | 2125698 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08732084.2 |
| Date of filing the European patent application | 2008-03-13 | |
| (97) | Date of publication of the European application | 2009-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-31 |
| (46) | Date of publication of the claims translation | 2016-10-10 |
| (86) | Number | PCT/US2008/056780 |
| Date | 2008-03-13 |
| (87) | Number | WO 2008/140859 |
| Date | 2008-11-20 |
| (30) | Number | Date | Country code |
| 895049 P | 2007-03-15 | US | |
| 944399 P | 2007-06-15 | US |
| (72) |
GANT, Thomas, G., US
SEPEHR, Sarshar, US
WOO, Soon, Hyung, US
|
| (73) |
Auspex Pharmaceuticals, Inc.,
3333 North Torrey Pine Court, Suite 400, La Jolla, CA 92037,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Deuterintas d9-venlafaksinas |
| DEUTERATED d9-VENLAFAXINE |
| Payment date | Validity (years) | Amount | |
| 2018-02-21 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-03-13 |